← Back to Search

Participants for Transcranial Alternating Current Stimulation

N/A
Waitlist Available
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before tacs, right after tacs, 30 minutes after tacs, and 1 hour after tacs
Awards & highlights

Study Summary

This trial is testing whether transcranial alternating current stimulation (tACS) or transcranial random noise stimulation (tRNS) can lower the resting and active motor thresholds. This would make it so that people with higher RMT and AMT would not need as high of intensities while stimulating the brain for treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before tacs, right after tacs, 30 minutes after tacs, and 1 hour after tacs
This trial's timeline: 3 weeks for screening, Varies for treatment, and before tacs, right after tacs, 30 minutes after tacs, and 1 hour after tacs for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Resting Motor Threshold
Secondary outcome measures
Active Motor Threshold

Trial Design

1Treatment groups
Experimental Treatment
Group I: ParticipantsExperimental Treatment1 Intervention
Each participant will have their resting and active motor threshold measured using the transcranial magnetic stimulation (TMS) device. Participants will receive tACS for 10 minutes in the first session and tRNS in the second session.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,516 Total Patients Enrolled

Media Library

Participants Clinical Trial Eligibility Overview. Trial Name: NCT05503823 — N/A
Transcranial Alternating Current Stimulation Research Study Groups: Participants
Transcranial Alternating Current Stimulation Clinical Trial 2023: Participants Highlights & Side Effects. Trial Name: NCT05503823 — N/A
Participants 2023 Treatment Timeline for Medical Study. Trial Name: NCT05503823 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation currently accepting new participants?

"Affirmative. Evidence supplied by clinicaltrials.gov demonstrates that this study is actively seeking participants, with the initial posting dating 9/16/2022 and most recent revision taking place on 9/15/2022. The trial requires 50 patients from a single medical centre to complete the experiment."

Answered by AI

To what extent has the participant pool grown for this medical experiment?

"That is correct. According to information available on clinicaltrials.gov, this study was initially posted on September 16th 2022 and has been actively recruiting ever since then. The trial is seeking 50 patients from a single medical facility."

Answered by AI

Is there an age restriction for participation in this research initiative?

"This trial requires that potential participants meet the age criteria of 18 to 70 years old."

Answered by AI

For which population is enrollment in the trial open?

"This trial requires 50 volunteers of ages 18-70 who possess brain and have a Montreal Cognitive Assessment score at least 26."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Investigating Transcranial Alternating Current Stimulation (tACS) Preconditioning Effects on Resting and Active Motor Threshold
2022. "Investigating Transcranial Alternating Current Stimulation (tACS) Preconditioning Effects on Resting and Active Motor Threshold". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05503823.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top